Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Giuseppe Consogno"'
Autor:
Giuseppe Consogno, Renato Longhi, Maria Pia Protti, Piero Zannini, Giulio Melloni, Mariacristina Crosti
Publikováno v:
176 (2006): 5093–5099.
info:cnr-pdr/source/autori:Crosti M., Longhi R., Consogno G., Melloni G., Zannini P., Protti M.P./titolo:Identification of novel subdominant epitopes on the carcinoembryonic antigen recognized by CD4(+) T cells of lung cancer patients/doi:/rivista:/anno:2006/pagina_da:5093/pagina_a:5099/intervallo_pagine:5093–5099/volume:176
info:cnr-pdr/source/autori:Crosti M., Longhi R., Consogno G., Melloni G., Zannini P., Protti M.P./titolo:Identification of novel subdominant epitopes on the carcinoembryonic antigen recognized by CD4(+) T cells of lung cancer patients/doi:/rivista:/anno:2006/pagina_da:5093/pagina_a:5099/intervallo_pagine:5093–5099/volume:176
The carcinoembryonic Ag (CEA) is an attractive target for immunotherapy because of its expression profile and role in tumor progression. To verify the existence of spontaneous anti-CEA CD4+ T cells in lung cancer patients, we first identified CEA seq
Autor:
Luca Gianotti, Laura Galli, Marco Braga, Giovanni Citterio, Oreste Gentilini, Marco Foppoli, Giuseppe Consogno, Claudio Fortis
Publikováno v:
Cancer Letters. 104:1-5
In 40 out of 99 patients (40.4%) with solid tumours of different tissue, but the same stage (IV), elevated serum levels of interleukin-10 were observed. The mean levels of the cytokine in patients with malignant melanoma (24.3 ng/ml), pancreatic (6.8
Autor:
Eraldo O. Bucci, Ugo Scaglietti, Laura Galli, Paola Matteucci, Giovanni Citterio, Claudio Fortis, Giuseppe Consogno
Publikováno v:
Clinical Immunology and Immunopathology. 76:142-147
Circulating levels of soluble intracellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin were measured in 20 advanced cancer patients at different times during recombinant interleukin-2 immunotherapy. The concentration of al
Autor:
Eraldo Bucci, Giovanni Citterio, Giuseppo Landonio, Claudio Fortis, Emilio Clementi, Giuseppe Consogno
Publikováno v:
Cancer Immunology Immunotherapy. 39:167-171
Interleukin-2 plays a crucial role in enhancing the antitumor immune response. Clinical trials, mainly in renal cell carcinoma and melanoma patients, have been carried out with encouraging results. Recent reports demonstrated that interleukin-2 thera
Autor:
Gabriele, Campi, Mariacristina, Crosti, Giuseppe, Consogno, Valeria, Facchinetti, Bianca M, Conti-Fine, Renato, Longhi, Giulia, Casorati, Paolo, Dellabona, Maria Pia, Protti
Publikováno v:
Cancer research. 63(23)
The carcinoembryonic antigen (CEA) is an attractive target for immunotherapeutic purposes because of its expression profile, its role in tumor progression, and its immunogenicity. However, CEA belongs to the CD66 immunoglobulin super-gene family that
Autor:
Angela Bachi, Maria Pia Protti, Giuseppe Consogno, Claudio Rugarli, Simona Manici, Catia Traversari, Bianca M. Conti-Fine, Valeria Facchinetti, Juergen Hammer
Publikováno v:
Blood. 101(3)
The molecular characterization of the CD4+ T-cell epitope repertoire on human tumor antigens would contribute to both clinical investigation and cancer immunotherapy. In particular, the identification of promiscuous epitopes would be beneficial to a
Autor:
A. Borri, Angelo A. Manfredi, Valérie S. Zimmermann, Giuseppe Consogno, Elena Rota Caremoli, Patrizia Rovere, Giovanni Citterio, Attilio Bondanza, Anna Guidetti, Claudio Rugarli
The factors determining the outcome of immunotherapy in metastatic renal cell carcinoma (RCC) patients remain elusive. Macrophages from normal donors that phagocytose apoptotic cells secrete the immunosuppressive cytokine IL-10 in vitro. Conversely,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::169062b349e79ed165064eb281010211
Autor:
Simona Manici, Maria Adele Imro, Paolo Dellabona, Maria Pia Protti, Silvia Heltai, Giuseppe Consogno, Matteo Bellone, Claudio Rugarli
Publikováno v:
Human gene therapy. 9(9)
Neoplastic cells express tumor-associated antigens, but tumor rejection seldom occurs in vivo. The absence of an effective immune response may be explained by the inability of tumor cells to deliver co-stimulatory signals. Indeed, transfection of eit
Autor:
Giuseppe Consogno, Claudio Fortis, Oreste Gentilini, Valerio Di Carlo, Luca Gianotti, Marco Braga
Objective: To investigate the impact of thymopentin (Thy) on mortality and in vivo cytokine release in an animal model of gut-derived sepsis which includes different combinations of allogeneic blood transfusion (T) and burn injury plus bacterial gava
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7ec0c9081aafe7a728f1285b0b28353
Autor:
Giuseppe Di Lucca, Claudio Fortis, C. Besana, Elisabetta Ferrero, Claudio Rugarli, Consuelo Corti, Silvia Heltai, Marco Foppoli, Giuseppe Consogno
Publikováno v:
European journal of cancer (Oxford, England : 1990). (3)
TO UNDERSTAND better the immunological reactions primed by interleukin-2 (IL-2) in cancer patients we have investigated the biological effects of systemic rIL-2 on the circulating lymphocytes of cancer patients [ 1, 21. We report here immunological t